Table 2.
Patient characteristics
| No. of patients | Median | Range | |
|---|---|---|---|
| Age (year) | 94 | 65 | 33–85 |
| Weight (kg) | 93 | 73 | 37–120 |
| BSA (m2) | 92 | 1.8 | 1.2–2.5 |
| Estimated CLCR (ml min−1) | 91 | 83 | 37–150 |
| Sex | |||
| Male | 68 | – | – |
| Female | 26 | – | – |
| Tumour type | |||
| NSCLC | 47 | – | – |
| Pancreatic | 14 | – | – |
| Diverse type | 33 | – | – |
| Gemcitabine/oxaliplatin | 38 | – | – |
| Oxaliplatin/gemcitabine | 25 | – | – |
| Gemcitabine alone | 31 | – | – |
| Infusion rate (mg min−1) | 94 | 55 | 15–95 |
BSA, Body surface area; NSCLC, nonsmall cell lung cancer.